These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 30898317)

  • 1. Hepatitis C is a risk factor for cardiovascular disease.
    Estrada V; Sagastagoitia I
    Rev Clin Esp (Barc); 2019; 219(6):322-323. PubMed ID: 30898317
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients.
    Fernández-Montero JV; Barreiro P; de Mendoza C; Labarga P; Soriano V
    J Viral Hepat; 2016 Jan; 23(1):47-52. PubMed ID: 26390144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic hepatitis C virus infection, a new cardiovascular risk factor?
    Domont F; Cacoub P
    Liver Int; 2016 May; 36(5):621-7. PubMed ID: 26763484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV, Cocaine Use, and Hepatitis C Virus: A Triad of Nontraditional Risk Factors for Subclinical Cardiovascular Disease.
    Lucas GM; Atta MG; Fine DM; McFall AM; Estrella MM; Zook K; Stein JH
    Arterioscler Thromb Vasc Biol; 2016 Oct; 36(10):2100-7. PubMed ID: 27609369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the Pooled Cohort atherosclerotic cardiovascular disease risk score in hepatitis C virus-infected persons.
    Chew KW; Bhattacharya D; Horwich TB; Yan P; McGinnis KA; Tseng C; Freiberg MS; Currier JS; Butt AA
    J Viral Hepat; 2017 Oct; 24(10):814-822. PubMed ID: 28273386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An outbreak of non-A, non-B hepatitis associated with the infusion of a commercial factor IX complex during cardiovascular surgery.
    Gerber AR; Englender SJ; Selvey D; Carlson JF; Matthews DL; Webster HM; Caldwell GG
    Vox Sang; 1990; 58(4):270-5. PubMed ID: 2119087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerotic Cardiovascular Disease in Individuals with Hepatitis C Viral Infection.
    Bailey AL; Al-Adwan S; Sneij E; Campbell N; Wiisanen ME
    Curr Cardiol Rep; 2021 Apr; 23(5):52. PubMed ID: 33822282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular events in chronic hepatitis C: prognostic value of liver stiffness evolution.
    Serres L; Vasseur P; Tougeron D; Gand E; Chagneau-Derrode C; Charier F; Rochd S; Silvain C
    Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1286-92. PubMed ID: 26275081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between hepatitis C infection and cerebro-cardiovascular disease: analysis of a national population-based survey in Egypt.
    Gadallah M; Kandil S; Mohsen A
    Trop Med Int Health; 2018 Jul; 23(7):738-747. PubMed ID: 29723920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individuals.
    Freiberg MS; Cheng DM; Kraemer KL; Saitz R; Kuller LH; Samet JH
    AIDS; 2007 Jan; 21(2):193-7. PubMed ID: 17197810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. REDUCED HAND GRIP STRENGTH IN OVERWEIGHT AND OBESE CHRONIC HEPATITIS C PATIENTS.
    Bruch JP; Álvares-DA-Silva MR; Alves BC; Dall'alba V
    Arq Gastroenterol; 2016; 53(1):31-5. PubMed ID: 27281502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disease and hepatitis C virus infection: an irrelevant statement or a hot relationship?
    Katsi V; Felekos I; Skevofilax S; Aggeli C; Tousoulis D; Stefanadis C; Kallikazaros I
    Cardiol Rev; 2015; 23(1):11-7. PubMed ID: 24926806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cardiovascular outcomes and all-cause mortality in patients with chronic hepatitis B and C: A 13-year nationwide population-based study in Asia.
    Wu VC; Chen TH; Wu M; Cheng CW; Chen SW; Chang CW; Chen CC; Chang SH; Hung KC; Chern MS; Lin FC; Chu PH; Wu CS
    Atherosclerosis; 2018 Feb; 269():178-184. PubMed ID: 29366991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreasing occupational risk related to blood-borne viruses in cardiovascular surgery in Paris, France.
    Kuo YH; Fabiani JN; Mohamed AS; Couetil JP; Lévy M; Gutmann L; Carpentier AF; Bélec L
    Ann Thorac Surg; 1999 Dec; 68(6):2267-72. PubMed ID: 10617015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse effects of interferon on the cardiovascular system in patients with chronic hepatitis C.
    Teragawa H; Hondo T; Amano H; Hino F; Ohbayashi M
    Jpn Heart J; 1996 Nov; 37(6):905-15. PubMed ID: 9057685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C as a risk factor for carotid atherosclerosis - a systematic review.
    Olubamwo OO; Onyeka IN; Miettola J; Kauhanen J; Tuomainen TP
    Clin Physiol Funct Imaging; 2016 Jul; 36(4):249-60. PubMed ID: 25620553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Autoimmune Hepatitis and Cardiovascular Disease.
    Persaud A; Ahmed A; Kakked G; Shulik O; Ahlawat S
    Dig Liver Dis; 2019 Nov; 51(11):1604-1609. PubMed ID: 31171486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of infection with hepatitis C virus on cardiovascular risk.
    Iorga RA; Bacalbasa N; Bratu OG; Ionita Radu F; Diaconu CC
    Am J Cardiovasc Dis; 2020; 10(3):201-206. PubMed ID: 32923102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments?
    Adinolfi LE; Rinaldi L; Nevola R
    World J Gastroenterol; 2018 Nov; 24(41):4617-4621. PubMed ID: 30416309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing cardiovascular risk in hepatitis C: An unmet need.
    Ampuero J; Romero-Gómez M
    World J Hepatol; 2015 Sep; 7(19):2214-9. PubMed ID: 26380047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.